Handelsbanken Fonder
RGNX icon

Handelsbanken Fonder’s Regenxbio RGNX Stock Holding History

Handelsbanken Fonder’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,400
Closed -$222K – 1601
2022
Q3 		$222K Hold
8,400
– – ﹤0.01% 1403
2022
Q2 		$207K Sell
8,400
-900
-10% -$22.5K ﹤0.01% 1488
2022
Q1 		$309K Hold
9,300
– – ﹤0.01% 1504
2021
Q4 		$304K Hold
9,300
– – ﹤0.01% 1608
2021
Q3 		$390K Hold
9,300
– – ﹤0.01% 1492
2021
Q2 		$361K Buy
9,300
+2,200
+31% +$78.7K ﹤0.01% 1571
2021
Q1 		$242K Hold
7,100
– – ﹤0.01% 1503
2020
Q4 		$322K Buy
+7,100
New +$248K ﹤0.01% 1371
2020
Q3 		– Sell
-7,100
Closed -$261K – 1466
2020
Q2 		$261K Buy
+7,100
New +$265K ﹤0.01% 1285

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Handelsbanken Fonder's RGNX Position: Q4 2022 in Review

Handelsbanken Fonder sold out of Regenxbio (RGNX) in Q4 2022, closing a stake of 8,400 shares — an estimated $222K sold.

Handelsbanken Fonder first reported a position in RGNX in Q2 2020 and held it in 9 quarters. The position peaked at $390K in Q3 2021. 182 funds tracked by Wall St. Rank hold RGNX as of Q4 2022.

  • Handelsbanken Fonder reported no remaining Regenxbio position as of Q4 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 8,400 Regenxbio shares in Q4 2022, an estimated $222K.
  • Handelsbanken Fonder first reported a position in Regenxbio in Q2 2020 and held it in 9 quarters.
  • Handelsbanken Fonder's Regenxbio position peaked at $390K in Q3 2021.
  • 182 funds tracked by Wall St. Rank held Regenxbio as of Q4 2022.

Based on Handelsbanken Fonder's 13F filing for Q4 2022, filed 7 Feb 2023.